Sandra Cristea
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- PARP inhibition in cancer therapy
- Immunology top 10%
- interferon and immune responses
Papers in
- Oncology 7
- Lung Cancer Research Studies 5
-
- CRISPR and Genetic Engineering 2
- Viral Infectious Diseases and Gene Expression in Insects 1
- Glycosylation and Glycoproteins Research 1
- Ubiquitin and proteasome pathways 1
- Co-authors
- Julien Sage (7 shared papers)Triparna Sen (3 shared papers)Lauren A. Byers (3 shared papers)Lerong Li (2 shared papers)Bonnie S. Glisson (2 shared papers)Jing Wang (2 shared papers)Don L. Gibbons (2 shared papers)John V. Heymach (2 shared papers)
- Journals
- Cancer Research (2 papers)Clinical Cancer Research (1 paper)Nature (1 paper)Biotechnology and Bioengineering (1 paper)Journal of Thoracic Oncology (1 paper)
- Partner nations
- United StatesFranceGermany
In The Last Decade
Sandra Cristea
9 papers receiving 1.6k citations
Sandra Cristea's Hit Papers
Peers
Comparison fields: 5 of 89
- Oncology 854
- Immunology 324
- Molecular Biology 850
- Cancer Research 140
- Epidemiology 259
Countries citing papers authored by Sandra Cristea
This map shows the geographic impact of Sandra Cristea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Cristea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Cristea more than expected).
Fields of papers citing papers by Sandra Cristea
This network shows the impact of papers produced by Sandra Cristea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Cristea. The network helps show where Sandra Cristea may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandra Cristea, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer Hit paper breakdown → | 2019 | 644 |
| 2 | 2017 | 328 | |
| 3 | 2019 | 214 | |
| 4 | 2012 | 152 | |
| 5 | 2017 | 149 | |
| 6 | 2020 | 55 | |
| 7 | 2016 | 45 | |
| 8 | 2018 | 43 | |
| 9 | 2011 | 5 |
About Sandra Cristea
Sandra Cristea is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Immunology, having authored 9 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (5 papers), Lung Cancer Treatments and Mutations (3 papers), Cancer Mechanisms and Therapy (2 papers), CRISPR and Genetic Engineering (2 papers), Viral Infectious Diseases and Gene Expression in Insects (1 paper), Glycosylation and Glycoproteins Research (1 paper), Galectins and Cancer Biology (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Oncology (854 citations), Immunology (324 citations), Molecular Biology (850 citations), Cancer Research (140 citations) and Epidemiology (259 citations). Sandra Cristea has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Julien Sage, Triparna Sen, Lauren A. Byers, Lerong Li, Bonnie S. Glisson, Jing Wang, Don L. Gibbons, John V. Heymach, You-Hong Fan and Naoto Morikawa. Their work appears in journals such as Cancer Research, Clinical Cancer Research, Nature, Biotechnology and Bioengineering and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.